Loading the company…
Loading the company…
㈜에스엘메디케어
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Seoul, founded in 2014. Industry: Wholesale & Retail. Revenue for 2025 was ₩10.9bn. It has 18 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2022-03-03 · latest registration 2024-03-28 · newest first
본 발명은 산소 발생 장치에 대한 것으로서, 특히 제올라이트 유닛 일 측에 구비되어 추출된 산소의 유량을 조절하는 유량 조절부를 포함하되, 상기 유량 조절부는 중공의 하우징과, 상기 하우징 내부에 회전 가능하게 구비되고 상기 제올라이트 유닛과 연통되는 실린더를 포함하며, 상기 실린더의 회전 각도에 의해 배출되는 산소의 유량을 제어하여 산소 유량을 정밀하게 제어할 수 있는 미세 유량 조절이 가능한 산소 발생 장치이다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 10.0 | 10.9 |
| Cost of sales | 3.4 | 4.0 |
| Gross profit (loss) | 6.6 | 6.9 |
| Selling, general and administrative expenses | 4.9 | 4.9 |
| Operating income (loss) | 1.7 | 2.1 |
| Non-operating income | 0.3 | 0.2 |
| Other gains | 0.2 | 0.1 |
| Finance income | 0.0 | 0.0 |
| Other | — | 0.0 |
| Non-operating expenses | 0.6 | 0.4 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 0.6 | 0.3 |
| Other | 0.0 | 0.0 |
| Profit (loss) before tax | 1.3 | 1.8 |
| Income tax expense | 0.1 | 0.5 |
| Net income (loss) | 1.3 | 1.4 |
Revenue ₩10.9bn, up 8.8% YoY.
Operating margin 19.1% (prior 16.9%).
Net income ₩1.4bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.